EMEA (Europe, Middle East and Africa) Gastrointestinal Drugs Market Report 2017

December 2017 | 100 pages | ID: EB796540B41EN
QYResearch

Abstracts

In this report, the EMEA Gastrointestinal Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (Units), revenue (Million USD), market share and growth rate of Gastrointestinal Drugs for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Gastrointestinal Drugs market competition by top manufacturers/players, with Gastrointestinal Drugs sales volume (Units), price (K USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• AstraZeneca
• Johnson & Johnson
• Salix Pharma
• Takeda Pharma
• Eisai
• Shire
• Allergan

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Capsules
• Inhalants
• Parenterals
• Tablets
• Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Antacid & Anti-Ulcerant
• GIT Anti-inflammatory
• Antiemetic
• Anti-diarrhoea
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Gastrointestinal Drugs Market Report 2017

1 GASTROINTESTINAL DRUGS OVERVIEW

1.1 Product Overview and Scope of Gastrointestinal Drugs
1.2 Classification of Gastrointestinal Drugs
  1.2.1 EMEA Gastrointestinal Drugs Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Gastrointestinal Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Capsules
  1.2.4 Inhalants
  1.2.5 Parenterals
  1.2.6 Tablets
  1.2.7 Other
1.3 EMEA Gastrointestinal Drugs Market by Application/End Users
  1.3.1 EMEA Gastrointestinal Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Antacid & Anti-Ulcerant
  1.3.3 GIT Anti-inflammatory
  1.3.4 Antiemetic
  1.3.5 Anti-diarrhoea
  1.3.6 Other
1.4 EMEA Gastrointestinal Drugs Market by Region
  1.4.1 EMEA Gastrointestinal Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Gastrointestinal Drugs (2012-2022)
  1.5.1 EMEA Gastrointestinal Drugs Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Gastrointestinal Drugs Revenue and Growth Rate (2012-2022)

2 EMEA GASTROINTESTINAL DRUGS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Gastrointestinal Drugs Market Competition by Players/Manufacturers
  2.1.1 EMEA Gastrointestinal Drugs Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Gastrointestinal Drugs Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Gastrointestinal Drugs Sale Price by Players (2012-2017)
2.2 EMEA Gastrointestinal Drugs (Volume and Value) by Type/Product Category
  2.2.1 EMEA Gastrointestinal Drugs Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Gastrointestinal Drugs Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Gastrointestinal Drugs Sale Price by Type (2012-2017)
2.3 EMEA Gastrointestinal Drugs (Volume) by Application
2.4 EMEA Gastrointestinal Drugs (Volume and Value) by Region
  2.4.1 EMEA Gastrointestinal Drugs Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Gastrointestinal Drugs Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Gastrointestinal Drugs Sales Price by Region (2012-2017)

3 EUROPE GASTROINTESTINAL DRUGS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Gastrointestinal Drugs Sales and Value (2012-2017)
  3.1.1 Europe Gastrointestinal Drugs Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Gastrointestinal Drugs Revenue and Growth Rate (2012-2017)
3.2 Europe Gastrointestinal Drugs Sales and Market Share by Type
3.3 Europe Gastrointestinal Drugs Sales and Market Share by Application
3.4 Europe Gastrointestinal Drugs Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Gastrointestinal Drugs Sales Volume by Countries (2012-2017)
  3.4.2 Europe Gastrointestinal Drugs Revenue by Countries (2012-2017)
  3.4.3 Germany Gastrointestinal Drugs Sales and Growth Rate (2012-2017)
  3.4.4 France Gastrointestinal Drugs Sales and Growth Rate (2012-2017)
  3.4.5 UK Gastrointestinal Drugs Sales and Growth Rate (2012-2017)
  3.4.6 Russia Gastrointestinal Drugs Sales and Growth Rate (2012-2017)
  3.4.7 Italy Gastrointestinal Drugs Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Gastrointestinal Drugs Sales and Growth Rate (2012-2017)

4 MIDDLE EAST GASTROINTESTINAL DRUGS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Gastrointestinal Drugs Sales and Value (2012-2017)
  4.1.1 Middle East Gastrointestinal Drugs Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Gastrointestinal Drugs Revenue and Growth Rate (2012-2017)
4.2 Middle East Gastrointestinal Drugs Sales and Market Share by Type
4.3 Middle East Gastrointestinal Drugs Sales and Market Share by Application
4.4 Middle East Gastrointestinal Drugs Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Gastrointestinal Drugs Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Gastrointestinal Drugs Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Gastrointestinal Drugs Sales and Growth Rate (2012-2017)
  4.4.4 Israel Gastrointestinal Drugs Sales and Growth Rate (2012-2017)
  4.4.5 UAE Gastrointestinal Drugs Sales and Growth Rate (2012-2017)
  4.4.6 Iran Gastrointestinal Drugs Sales and Growth Rate (2012-2017)

5 AFRICA GASTROINTESTINAL DRUGS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Gastrointestinal Drugs Sales and Value (2012-2017)
  5.1.1 Africa Gastrointestinal Drugs Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Gastrointestinal Drugs Revenue and Growth Rate (2012-2017)
5.2 Africa Gastrointestinal Drugs Sales and Market Share by Type
5.3 Africa Gastrointestinal Drugs Sales and Market Share by Application
5.4 Africa Gastrointestinal Drugs Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Gastrointestinal Drugs Sales Volume by Countries (2012-2017)
  5.4.2 Africa Gastrointestinal Drugs Revenue by Countries (2012-2017)
  5.4.3 South Africa Gastrointestinal Drugs Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Gastrointestinal Drugs Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Gastrointestinal Drugs Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Gastrointestinal Drugs Sales and Growth Rate (2012-2017)

6 EMEA GASTROINTESTINAL DRUGS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 AstraZeneca
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Gastrointestinal Drugs Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 AstraZeneca Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Johnson & Johnson
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Gastrointestinal Drugs Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Johnson & Johnson Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Salix Pharma
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Gastrointestinal Drugs Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Salix Pharma Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Takeda Pharma
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Gastrointestinal Drugs Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Takeda Pharma Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Eisai
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Gastrointestinal Drugs Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Eisai Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Shire
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Gastrointestinal Drugs Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Shire Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Allergan
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Gastrointestinal Drugs Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Allergan Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview

7 GASTROINTESTINAL DRUGS MANUFACTURING COST ANALYSIS

7.1 Gastrointestinal Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Gastrointestinal Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Gastrointestinal Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Gastrointestinal Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA GASTROINTESTINAL DRUGS MARKET FORECAST (2017-2022)

11.1 EMEA Gastrointestinal Drugs Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Gastrointestinal Drugs Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Gastrointestinal Drugs Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Gastrointestinal Drugs Price and Trend Forecast (2017-2022)
11.2 EMEA Gastrointestinal Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Gastrointestinal Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Gastrointestinal Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Gastrointestinal Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Gastrointestinal Drugs Sales Forecast by Type (2017-2022)
11.7 EMEA Gastrointestinal Drugs Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Gastrointestinal Drugs
Figure EMEA Gastrointestinal Drugs Sales Volume (Units) by Type (2012-2022)
Figure EMEA Gastrointestinal Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Capsules Product Picture
Figure Inhalants Product Picture
Figure Parenterals Product Picture
Figure Tablets Product Picture
Figure Other Product Picture
Figure EMEA Gastrointestinal Drugs Sales Volume (Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Gastrointestinal Drugs by Application in 2016
Figure Antacid & Anti-Ulcerant Examples
Table Key Downstream Customer in Antacid & Anti-Ulcerant
Figure GIT Anti-inflammatory Examples
Table Key Downstream Customer in GIT Anti-inflammatory
Figure Antiemetic Examples
Table Key Downstream Customer in Antiemetic
Figure Anti-diarrhoea Examples
Table Key Downstream Customer in Anti-diarrhoea
Figure Other Examples
Table Key Downstream Customer in Other
Figure EMEA Gastrointestinal Drugs Market Size (Million USD) by Region (2012-2022)
Figure Europe Gastrointestinal Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Gastrointestinal Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Gastrointestinal Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Gastrointestinal Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Africa Gastrointestinal Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Gastrointestinal Drugs Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Gastrointestinal Drugs Sales Volume and Growth Rate (2012-2022)
Figure EMEA Gastrointestinal Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Gastrointestinal Drugs Market Major Players Product Sales Volume (Units) (2012-2017)
Table EMEA Gastrointestinal Drugs Sales Volume (Units) of Major Players (2012-2017)
Table EMEA Gastrointestinal Drugs Sales Share by Players (2012-2017)
Figure 2016 Gastrointestinal Drugs Sales Share by Players
Figure 2017 Gastrointestinal Drugs Sales Share by Players
Figure EMEA Gastrointestinal Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Gastrointestinal Drugs Revenue (Million USD) by Players (2012-2017)
Table EMEA Gastrointestinal Drugs Revenue Share by Players (2012-2017)
Table 2016 EMEA Gastrointestinal Drugs Revenue Share by Players
Table 2017 EMEA Gastrointestinal Drugs Revenue Share by Players
Table EMEA Gastrointestinal Drugs Sale Price (K USD/Unit) by Players (2012-2017)
Table EMEA Gastrointestinal Drugs Sales (Units) and Market Share by Type (2012-2017)
Table EMEA Gastrointestinal Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Gastrointestinal Drugs by Type (2012-2017)
Figure EMEA Gastrointestinal Drugs Sales Market Share by Type (2012-2017)
Table EMEA Gastrointestinal Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Gastrointestinal Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Gastrointestinal Drugs by Type in 2016
Table EMEA Gastrointestinal Drugs Sale Price (K USD/Unit) by Type (2012-2017)
Table EMEA Gastrointestinal Drugs Sales (Units) and Market Share by Application (2012-2017)
Table EMEA Gastrointestinal Drugs Sales Share by Application (2012-2017)
Figure Sales Market Share of Gastrointestinal Drugs by Application (2012-2017)
Figure EMEA Gastrointestinal Drugs Sales Market Share by Application in 2016
Table EMEA Gastrointestinal Drugs Sales (Units) and Market Share by Region (2012-2017)
Table EMEA Gastrointestinal Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Gastrointestinal Drugs by Region (2012-2017)
Figure EMEA Gastrointestinal Drugs Sales Market Share in 2016
Table EMEA Gastrointestinal Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Gastrointestinal Drugs Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Gastrointestinal Drugs by Region (2012-2017)
Figure EMEA Gastrointestinal Drugs Revenue Market Share Regions in 2016
Table EMEA Gastrointestinal Drugs Sales Price (K USD/Unit) by Region (2012-2017)
Figure Europe Gastrointestinal Drugs Sales (Units) and Growth Rate (2012-2017)
Figure Europe Gastrointestinal Drugs Revenue and Growth Rate (2012-2017)
Table Europe Gastrointestinal Drugs Sales (Units) by Type (2012-2017)
Table Europe Gastrointestinal Drugs Market Share by Type (2012-2017)
Figure Europe Gastrointestinal Drugs Market Share by Type in 2016
Table Europe Gastrointestinal Drugs Sales (Units) by Application (2012-2017)
Table Europe Gastrointestinal Drugs Market Share by Application (2012-2017)
Figure Europe Gastrointestinal Drugs Market Share by Application in 2016
Table Europe Gastrointestinal Drugs Sales (Units) by Countries (2012-2017)
Table Europe Gastrointestinal Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Gastrointestinal Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Gastrointestinal Drugs Sales Market Share by Countries in 2016
Table Europe Gastrointestinal Drugs Revenue (Million USD) by Countries (2012-2017)
Table Europe Gastrointestinal Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Gastrointestinal Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Gastrointestinal Drugs Revenue Market Share by Countries in 2016
Figure Germany Gastrointestinal Drugs Sales (Units) and Growth Rate (2012-2017)
Figure France Gastrointestinal Drugs Sales (Units) and Growth Rate (2012-2017)
Figure UK Gastrointestinal Drugs Sales (Units) and Growth Rate (2012-2017)
Figure Russia Gastrointestinal Drugs Sales (Units) and Growth Rate (2012-2017)
Figure Italy Gastrointestinal Drugs Sales (Units) and Growth Rate (2012-2017)
Figure Benelux Gastrointestinal Drugs Sales (Units) and Growth Rate (2012-2017)
Figure Middle East Gastrointestinal Drugs Sales (Units) and Growth Rate (2012-2017)
Figure Middle East Gastrointestinal Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Gastrointestinal Drugs Sales (Units) by Type (2012-2017)
Table Middle East Gastrointestinal Drugs Market Share by Type (2012-2017)
Figure Middle East Gastrointestinal Drugs Market Share by Type (2012-2017)
Table Middle East Gastrointestinal Drugs Sales (Units) by Applications (2012-2017)
Table Middle East Gastrointestinal Drugs Market Share by Applications (2012-2017)
Figure Middle East Gastrointestinal Drugs Sales Market Share by Application in 2016
Table Middle East Gastrointestinal Drugs Sales Volume (Units) by Countries (2012-2017)
Table Middle East Gastrointestinal Drugs Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Gastrointestinal Drugs Sales Volume Market Share by Countries in 2016
Table Middle East Gastrointestinal Drugs Revenue (Million USD) by Countries (2012-2017)
Table Middle East Gastrointestinal Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Gastrointestinal Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Gastrointestinal Drugs Revenue Market Share by Countries in 2016
Figure Saudi Arabia Gastrointestinal Drugs Sales (Units) and Growth Rate (2012-2017)
Figure Israel Gastrointestinal Drugs Sales (Units) and Growth Rate (2012-2017)
Figure UAE Gastrointestinal Drugs Sales (Units) and Growth Rate (2012-2017)
Figure Iran Gastrointestinal Drugs Sales (Units) and Growth Rate (2012-2017)
Figure Africa Gastrointestinal Drugs Sales (Units) and Growth Rate (2012-2017)
Figure Africa Gastrointestinal Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Gastrointestinal Drugs Sales (Units) by Type (2012-2017)
Table Africa Gastrointestinal Drugs Sales Market Share by Type (2012-2017)
Figure Africa Gastrointestinal Drugs Sales Market Share by Type (2012-2017)
Figure Africa Gastrointestinal Drugs Sales Market Share by Type in 2016
Table Africa Gastrointestinal Drugs Sales (Units) by Application (2012-2017)
Table Africa Gastrointestinal Drugs Sales Market Share by Application (2012-2017)
Figure Africa Gastrointestinal Drugs Sales Market Share by Application (2012-2017)
Table Africa Gastrointestinal Drugs Sales Volume (Units) by Countries (2012-2017)
Table Africa Gastrointestinal Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Gastrointestinal Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Gastrointestinal Drugs Sales Market Share by Countries in 2016
Table Africa Gastrointestinal Drugs Revenue (Million USD) by Countries (2012-2017)
Table Africa Gastrointestinal Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Gastrointestinal Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Gastrointestinal Drugs Revenue Market Share by Countries in 2016
Figure South Africa Gastrointestinal Drugs Sales (Units) and Growth Rate (2012-2017)
Figure Nigeria Gastrointestinal Drugs Sales (Units) and Growth Rate (2012-2017)
Figure Egypt Gastrointestinal Drugs Sales (Units) and Growth Rate (2012-2017)
Figure Algeria Gastrointestinal Drugs Sales (Units) and Growth Rate (2012-2017)
Table AstraZeneca Gastrointestinal Drugs Basic Information List
Table AstraZeneca Gastrointestinal Drugs Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Gastrointestinal Drugs Sales (Units) and Growth Rate (2012-2017)
Figure AstraZeneca Gastrointestinal Drugs Sales Market Share in EMEA (2012-2017)
Figure AstraZeneca Gastrointestinal Drugs Revenue Market Share in EMEA (2012-2017)
Table Johnson & Johnson Gastrointestinal Drugs Basic Information List
Table Johnson & Johnson Gastrointestinal Drugs Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Johnson & Johnson Gastrointestinal Drugs Sales (Units) and Growth Rate (2012-2017)
Figure Johnson & Johnson Gastrointestinal Drugs Sales Market Share in EMEA (2012-2017)
Figure Johnson & Johnson Gastrointestinal Drugs Revenue Market Share in EMEA (2012-2017)
Table Salix Pharma Gastrointestinal Drugs Basic Information List
Table Salix Pharma Gastrointestinal Drugs Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Salix Pharma Gastrointestinal Drugs Sales (Units) and Growth Rate (2012-2017)
Figure Salix Pharma Gastrointestinal Drugs Sales Market Share in EMEA (2012-2017)
Figure Salix Pharma Gastrointestinal Drugs Revenue Market Share in EMEA (2012-2017)
Table Takeda Pharma Gastrointestinal Drugs Basic Information List
Table Takeda Pharma Gastrointestinal Drugs Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Takeda Pharma Gastrointestinal Drugs Sales (Units) and Growth Rate (2012-2017)
Figure Takeda Pharma Gastrointestinal Drugs Sales Market Share in EMEA (2012-2017)
Figure Takeda Pharma Gastrointestinal Drugs Revenue Market Share in EMEA (2012-2017)
Table Eisai Gastrointestinal Drugs Basic Information List
Table Eisai Gastrointestinal Drugs Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Eisai Gastrointestinal Drugs Sales (Units) and Growth Rate (2012-2017)
Figure Eisai Gastrointestinal Drugs Sales Market Share in EMEA (2012-2017)
Figure Eisai Gastrointestinal Drugs Revenue Market Share in EMEA (2012-2017)
Table Shire Gastrointestinal Drugs Basic Information List
Table Shire Gastrointestinal Drugs Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Shire Gastrointestinal Drugs Sales (Units) and Growth Rate (2012-2017)
Figure Shire Gastrointestinal Drugs Sales Market Share in EMEA (2012-2017)
Figure Shire Gastrointestinal Drugs Revenue Market Share in EMEA (2012-2017)
Table Allergan Gastrointestinal Drugs Basic Information List
Table Allergan Gastrointestinal Drugs Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Allergan Gastrointestinal Drugs Sales (Units) and Growth Rate (2012-2017)
Figure Allergan Gastrointestinal Drugs Sales Market Share in EMEA (2012-2017)
Figure Allergan Gastrointestinal Drugs Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Gastrointestinal Drugs
Figure Manufacturing Process Analysis of Gastrointestinal Drugs
Figure Gastrointestinal Drugs Industrial Chain Analysis
Table Raw Materials Sources of Gastrointestinal Drugs Major Manufacturers in 2016
Table Major Buyers of Gastrointestinal Drugs
Table Distributors/Traders List
Figure EMEA Gastrointestinal Drugs Sales (Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Gastrointestinal Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Gastrointestinal Drugs Price (K USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Gastrointestinal Drugs Sales (Units) Forecast by Region (2017-2022)
Figure EMEA Gastrointestinal Drugs Sales Market Share Forecast by Region (2017-2022)
Table EMEA Gastrointestinal Drugs Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Gastrointestinal Drugs Revenue Market Share Forecast by Region (2017-2022)
Table Europe Gastrointestinal Drugs Sales (Units) Forecast by Countries (2017-2022)
Figure Europe Gastrointestinal Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Europe Gastrointestinal Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Gastrointestinal Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Gastrointestinal Drugs Sales (Units) Forecast by Countries (2017-2022)
Figure Middle East Gastrointestinal Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Gastrointestinal Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Gastrointestinal Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Gastrointestinal Drugs Sales (Units) Forecast by Countries (2017-2022)
Figure Africa Gastrointestinal Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Africa Gastrointestinal Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Gastrointestinal Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Gastrointestinal Drugs Sales (Units) Forecast by Type (2017-2022)
Figure EMEA Gastrointestinal Drugs Sales Market Share Forecast by Type (2017-2022)
Table EMEA Gastrointestinal Drugs Sales (Units) Forecast by Application (2017-2022)
Figure EMEA Gastrointestinal Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources